Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.02 (+0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Artelo Biosciences (ARTL) Total Debt (2017 - 2026)

Updated

Artelo Biosciences (ARTL) recorded Total Debt of $470,000 in Q1 2026, up 7.6% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Total Debt (2017 - 2026) Analysis & Trends

At the end of FY2025, Artelo Biosciences reported Total Debt of $437,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 Artelo Biosciences 49.32 Mn 32.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 470,000.00
Dec 31, 2025 437,000.00
Sep 30, 2025 875,000.00
Jun 30, 2025 791,000.00
May 31, 2017 29,720.00
Feb 28, 2017 29,569.00
API Access

Artelo Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ARTL&period=max&api_key=YOUR_API_KEY